Solventum (NYSE:SOLV – Get Free Report) is one of 238 publicly-traded companies in the “Surgical & medical instruments” ...

As of Dec. 31, the company still had $7.81 billion in long-term debt. Solventum sold off its purification and filtration ...

Solventum detailed its 2025-2028 growth strategy, reaffirmed its 2025 guidance, and reported Q4 earnings that topped expectations with strong sales and EPS.

Solventum’s Purification & Filtration business provides purification and filtration technologies for the production of biologics, medical technologies, and industrial applications.

Maplewood, Minnesota-based Solventum Corporation (SOLV) is a healthcare company specializing in developing, manufacturing, ...

Maplewood, Minnesota-based Solventum Corporation (SOLV) is a healthcare company specializing in developing, manufacturing, and commercializing solutions to address critical customer and patient needs.

The global Traditional Wound Care Market , valued at US$7.15 billion in 2024, is forecasted to grow at a robust CAGR of 4.2%, ...

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Solventum, the 3M healthcare spinoff, eliminated 800 ...

Solventum (NYSE: SOLV) today hosts its 2025 Investor Day and will outline strategic priorities for the Company, its business ...